Table 1.
Study | Country | Baseline, y | Setting (Occupational vs Population‐Based) | n, Participants | Mean (Rangea) Baseline Age (y) | n (%) Men | n (%) Job Strain at Baseline | Mean (SD) Follow‐Up (y) | n With PAD (Incidence Per 10 000 Person‐Years) |
---|---|---|---|---|---|---|---|---|---|
COPSOQ‐I10 | Denmark | 1997 | Population | 1769 | 40.7 (23–57) | 908 (51.3) | 363 (20.5) | 11.7 (1.6) | 16 (7.71) |
COPSOQ‐II11 | Denmark | 2004 to 2005 | Population | 3424 | 42.8 (25–58) | 1630 (47.6) | 486 (14.2) | 5.0 (0.4) | 12 (7.71) |
DWECS12, 13 | Denmark | 2000 | Population | 5563 | 41.8 (23–59) | 2963 (53.3) | 1239 (22.3) | 8.8 (1.2) | 37 (7.53) |
FPS14 | Finland | 2000 to 2004 | Occupational | 65 495 | 43.7 (17–69) | 13 104 (20.0) | 17 859 (27.3) | 9.8 (1.8) | 110 (1.72) |
HeSSup15 | Finland | 1998 and 2003 | Population | 18 465 | 38.6 (20–59) | 7760 (42.0) | 5203 (28.2) | 13.1 (2.2) | 55 (2.28) |
HHS16 | Finland | 2000 to 2002 | Occupational | 6448 | 49.2 (39–60) | 1397 (21.7) | 1001 (15.5) | 14.4 (1.8) | 41 (4.41) |
IPAW17, 18 | Denmark | 1996 to 1997 | Occupational | 2025 | 41.2 (24–57) | 672 (33.1) | 355 (17.5) | 12.8 (1.9) | 25 (9.66) |
SLOSH19 | Sweden | 2006 to 2008 | Population | 10 974 | 47.7 (19–68) | 5063 (46.1) | 2223 (20.3) | 6.5 (1.2) | 16 (2.23) |
Still Working20, 21 | Finland | 1986 | Occupational | 9154 | 40.9 (18–65) | 7071 (77.2) | 1424 (15.6) | 21.7 (4.0) | 161 (8.11) |
Whitehall II22 | United Kingdom | 1985 to 1988 | Occupational | 10 153 | 44.4 (34–56) | 6799 (70,0) | 1417 (14.0) | 26.8 (4.6) | 159 (5.82) |
WOLF S23 | Sweden | 1992 | Occupational | 5662 | 41.5 (19–70) | 3216 (56.8) | 919 (16.2) | 15.5 (2.2) | 35 (3.98) |
COPSOQ‐I and –II indicates Copenhagen Psychosocial Questionnaire versions I and II; DWECS, Danish Work Environment Cohort Study; FPS, Finnish Public Sector study; HeSSup, Health and Social Support; HHS, Helsinki Health Study; IPAW, Intervention Project on Absence and Well‐being; PAD, peripheral artery disease; SLOSH, Swedish Longitudinal Occupational Survey of Health; and WOLF S, Work, Lipids and Fibrinogen Stockholm.
5th and 95th percentiles are presented for COPSOQ‐I, COPSOQ‐II, DWECS, and IPAW for data security reasons.